Tuesday , October 24 2017
Home / Resources / Clinical Presentations / Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 5 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 5 of 5

DCMS52_HS

This week we conclude our five-part series of Homerun Slides on Pathophysiology in the Treatment of Type 2 Diabetes: New Agents. This week’s slides include coverage of Liraglutide and Pramlintide….

Link to download (.ppt format): Pathophysiology in the Treatment of Type 2 Diabetes: New Agents, Part 5 of 5

Other sets in this series:

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 1 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 2 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 3 of 5

Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 4 of 5

 

Check out all of Diabetes In Control’s slide collections at our new Clinical Presentations Library.